📰 Given Amgen News
Given Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Amgen. Real-time updates on events, politics, business and more.
November 13, 2023
Virbac (OTC:VRBCF – Get Free Report) and Amgen (NASDAQ:AMGN – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Insider and Institutional Ownership 24.3% of Virbac shares are held […]
November 7, 2023
Amgen (NASDAQ:AMGN – Get Free Report) and Virbac (OTC:VRBCF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Dividends Amgen pays an annual dividend of $8.52 per share […]
July 31, 2023
Amgen (NASDAQ:AMGN – Get Free Report) and Ono Pharmaceutical (OTCMKTS:OPHLY – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations. Analyst Ratings This is a summary of current ratings […]
June 1, 2023
ERYTECH Pharma (NASDAQ:ERYP – Get Rating) and Amgen (NASDAQ:AMGN – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings. Institutional & Insider Ownership 4.8% of ERYTECH Pharma shares are owned […]
June 1, 2023
Amgen (NASDAQ:AMGN – Get Rating) and ERYTECH Pharma (NASDAQ:ERYP – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability. Insider and Institutional Ownership 75.5% of Amgen shares are owned by […]
May 1, 2023
Amgen (NASDAQ:AMGN – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation. Profitability This table compares Amgen and PharmaCyte Biotech’s net margins, return […]
February 19, 2023
Amgen (NASDAQ:AMGN – Get Rating) and Quantum Genomics Société Anonyme (OTCMKTS:QNNTF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation. Profitability This table compares Amgen and Quantum Genomics Société […]